Objective 5: National programmes will be updated to overcome barriers to respond to HIV, TB and HCV-related needs in the EU, specifically in the focus countries.


    The deliverables of this work package gives stakeholders a clear picture of existing barriers in terms of harm reduction, HIV, HCV and TB services and offer strategies and actions to overcome such barriers, including pooling and efficient management of resources to explicitly target the groups in most need. 

    REPORT "The financing and sustainability of harm reduction services in the EU"

    Tailored guidance document on the utilisation of funding mechanisms for actions on HIV/AIDS hepatitis and TB, specifically addressing resource allocation and mobilisation and the use of diversified funding approaches to reach priority groups, particularly PWID. The document will be piloted in the focus countries.

    REPORT "An assessment of barriers to access to HIV and HCV services for people who inject drugs in Europe"

    An action-oriented report (with annexes for each focus country) in non-technical language for stakeholders, such as policy-makers and NGOs, on PWID barriers to accessing HIV, HCV and TB services and on strategies for overcoming these barriers;

    Lead: Jeffrey V. Lazarus, CHIP (REGIONH), University of Copenhagen, Denmark,

    Outputs & activities

    • “Tips sheets” on structural funds and joint procurement.
    • Meeting on sustainable funding in October 2016 (Budapest, Hungary).
    • Survey conducted on harm reduction services in Europe for removing provider-, customer-dependant and structural barriers in implementing acceptable and accessible high-quality HIV, hepatitis and TB services to PWID.
    • Meeting on the financing of harm reduction services and their sustainability in April 2017 (Vilnius, Lithuania).
    • Prepared and carried out open-ended survey to map barriers for PWID access to HIV, hepatitis and TB services. Survey closed on 18 May 2017. Results were presented at Addictions Conference in Lisbon, Portugal in October 2017.
    • Literature review is in process to compliment the survey results; on barriers to accessing HIV and hepatitis services, including harm reduction and treatment, globally and in Europe specifically. Prepared draft review and is being finalized as results are circulated to all WP leaders.
    • Drafted review of current policy environments in focus countries and implementation of national policies in relation to services for prisoners and PWID. Policy reviews from Hungary, Latvia and Lithuania are currently being finalized by Denmark and will be supplemented with a statistical annex.
    • Chaired final session with EU stakeholders in Budapest on harm reduction funding at final meeting of project “Harm reduction works – Fund it!” in October 2016.
    • Held second meeting on funding for harm reduction at EHRN “1st Regional Conference for Central and Eastern Europe and Central Asia” in Vilnius Lithuania (April 2017). HA-REACT meeting geared towards regional planning and sharing knowledge and experience, with objective to coordinate and improve funding and sustainability efforts for harm reduction services. Attendees included clinicians, NGOs, independent consultants, public health experts, and national representatives from health institutions.
    • HA-REACT jointly convened a session with Harm Reduction International in Budapest on what role HA-React would play in the continuity of actions which were taking place around improving the situation of funding for harm reduction within the EU.
    • Certain key experts on the issues surrounding sustainable funding and harm reduction were identified at the event and agreed to contribute to a roundtable article and blog series which HA-REACT will commission.
    • The second meeting on financing and sustainability of harm reduction services followed on the 6th of April 2017 as part of Regional Harm Reduction Conference in Vilnius (Lithuania). During this session two tips sheets were prepared and presented on EU Structural Funds and Joint Procurement. Consultant from Croatia, Poland and Spain presented their country reports on harm reduction funding. The session closed with an open panel discussion on the next steps looking at the following two questions: What does a country need for successful harm reduction financing and sustainability? And what can our organisations do to support this?
    • A report on the meeting was circulated to all participants including the executive summaries of the consultancy reports. It is available as a publication on the HA-REACT website.
    • A survey among service providers and service provider networks was conducted to assess the barriers that PWID face in access and treatment to HIV and HCV services. The survey was sent to organizations that provide harm reduction services in all 28 member states of the European Union on 29 March 2017. The contact information for these organizations was provided by the Correlation Network. The survey was closed on 17 May 2017 after at least one organization per country responded

    Twitter News